Research output: Contribution to journal › Article › peer-review
Kulachelvy Ratnasothy, Jacintha Jacob, Sim Lai Tung, Dominic Anthony Boardman, Robert Ian Lechler, Alberto Sanchez Fueyo, Marc Martinez-Llordella, Giovanna Lombardi
Original language | English |
---|---|
Pages (from-to) | 2092-2100 |
Number of pages | 9 |
Journal | American Journal of Transplantation |
Volume | 19 |
Issue number | 7 |
Early online date | 12 Feb 2019 |
DOIs | |
Accepted/In press | 26 Jan 2019 |
E-pub ahead of print | 12 Feb 2019 |
Published | Jul 2019 |
Additional links |
IL-2 therapy preferentially expands_RATNASOTHY_Accepted 26 January 2019_GOLD VoR (CC BY)
IL_2_therapy_preferentially_expands_RATNASOTHY_Accepted_26_January_2019_GOLD_VoR_CC_BY_.pdf, 1.37 MB, application/pdf
Uploaded date:26 Jun 2019
Version:Final published version
Licence:CC BY
Regulatory T cells (Tregs) have unique immunosuppressive properties and are essential to ensure effective immunoregulation. In animal models, Tregs have been shown to prevent autoimmune disorders and establish transplantation tolerance. Therefore, the prospect of harnessing Tregs, either by increasing their frequency or by conferring allospecificity, has prompted a growing interest in the development of immunotherapies. Here, employing a well-established skin transplant model with a single major histocompatibility complex mismatch, we compared the therapeutic efficacy of adoptively transfer Treg with or without donor specificity and the administration of IL-2 to promote in vivo expansion of Treg. We showed that IL-2 treatment preferentially enhances the proliferation of the allospecific Tregs adoptively transferred in an antigen-dependent manner. In addition, donor-specific Tregs significantly increased the expression of regulatory-related marker, such as CTLA4 and inducible costimulator (ICOS), in the skin allograft and draining lymph nodes compared to endogenous and polyclonal transferred Tregs. Importantly, by combining IL-2 with donor-specific Tregs, but not with polyclonal Tregs, a synergistic effect in prolonging skin allograft survival was observed. Altogether, our data suggest that this combination therapy could provide the appropriate conditions to enhance the immunoregulation of alloimmune responses in clinical transplantation.
King's College London - Homepage
© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454